Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 575

1.

CLINICAL PRACTICE. Genital Herpes.

Gnann JW Jr, Whitley RJ.

N Engl J Med. 2016 Aug 18;375(7):666-74. doi: 10.1056/NEJMcp1603178. Review. No abstract available.

PMID:
27532832
2.
4.

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

Blevins TP, Mitchell MC, Korom M, Wang H, Yu Y, Morrison LA, Belshe RB.

PLoS One. 2015 Dec 14;10(12):e0144738. doi: 10.1371/journal.pone.0144738. eCollection 2015.

5.

Mixed primary infection by herpes simplex virus 1 and 2 in a 5-month-old infant with no evidence of sexual abuse.

Patwardhan V, Bhalla P, Sardana K, Sethi S.

Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):612-4. doi: 10.4103/0378-6323.168340. No abstract available.

6.

Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM.

PLoS One. 2015 Oct 28;10(10):e0140765. doi: 10.1371/journal.pone.0140765. eCollection 2015.

7.

Selenoacyclovir and Selenoganciclovir: Discovery of a New Template for Antiviral Agents.

Sahu PK, Umme T, Yu J, Nayak A, Kim G, Noh M, Lee JY, Kim DD, Jeong LS.

J Med Chem. 2015 Nov 12;58(21):8734-8. doi: 10.1021/acs.jmedchem.5b00804. Epub 2015 Oct 23.

PMID:
26460883
8.

Seroprevalence of Herpes Simplex Virus Type 1 and Type 2 and Coinfection With HIV and Syphilis: The First National Seroprevalence Survey in Saudi Arabia.

Memish ZA, Almasri M, Chentoufi AA, Al-Tawfiq JA, Al-Shangiti AM, Al-Kabbani KM, Otaibi B, Assirri A, Yezli S.

Sex Transm Dis. 2015 Sep;42(9):526-32. doi: 10.1097/OLQ.0000000000000336.

PMID:
26267880
9.

Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.

Shen JH, Huang KY, Chao-Yu C, Chen CJ, Lin TY, Huang YC.

PLoS One. 2015 Aug 7;10(8):e0134178. doi: 10.1371/journal.pone.0134178. eCollection 2015.

10.

Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.

Boukhvalova M, McKay J, Mbaye A, Sanford-Crane H, Blanco JC, Huber A, Herold BC.

J Virol. 2015 Oct;89(19):9825-40. doi: 10.1128/JVI.01387-15. Epub 2015 Jul 15.

11.

Neonatal Herpes Simplex Virus Infection.

James SH, Kimberlin DW.

Infect Dis Clin North Am. 2015 Sep;29(3):391-400. doi: 10.1016/j.idc.2015.05.001. Epub 2015 Jul 4. Review.

PMID:
26154662
13.

Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.

Lamers SL, Newman RM, Laeyendecker O, Tobian AA, Colgrove RC, Ray SC, Koelle DM, Cohen J, Knipe DM, Quinn TC.

J Virol. 2015 Aug;89(16):8206-18. doi: 10.1128/JVI.01302-15. Epub 2015 May 27.

14.

Dynasore disrupts trafficking of herpes simplex virus proteins.

Mues MB, Cheshenko N, Wilson DW, Gunther-Cummins L, Herold BC.

J Virol. 2015 Jul;89(13):6673-84. doi: 10.1128/JVI.00636-15. Epub 2015 Apr 15.

15.

The effect of menopause on the innate antiviral activity of cervicovaginal lavage.

Chappell CA, Isaacs CE, Xu W, Meyn LA, Uranker K, Dezzutti CS, Moncla BJ, Hillier SL.

Am J Obstet Gynecol. 2015 Aug;213(2):204.e1-6. doi: 10.1016/j.ajog.2015.03.045. Epub 2015 Mar 25.

16.

Novel rat models to study primary genital herpes simplex virus-2 infection.

Önnheim K, Ekblad M, Görander S, Lange S, Jennische E, Bergström T, Wildt S, Liljeqvist JÅ.

Arch Virol. 2015 May;160(5):1153-61. doi: 10.1007/s00705-015-2365-7. Epub 2015 Feb 21.

PMID:
25701211
17.

Non-healing genital herpes mimicking donovanosis in an immunocompetent man.

Gupta V, Khute P, Patel A, Gupta S.

Int J STD AIDS. 2016 Jan;27(1):72-4. doi: 10.1177/0956462415568983. Epub 2015 Jan 22.

PMID:
25614521
18.

Herpes simplex virus infection during pregnancy.

Stephenson-Famy A, Gardella C.

Obstet Gynecol Clin North Am. 2014 Dec;41(4):601-14. doi: 10.1016/j.ogc.2014.08.006. Epub 2014 Oct 5. Review.

PMID:
25454993
19.

Animal models of herpes simplex virus immunity and pathogenesis.

Kollias CM, Huneke RB, Wigdahl B, Jennings SR.

J Neurovirol. 2015 Feb;21(1):8-23. doi: 10.1007/s13365-014-0302-2. Epub 2014 Nov 12. Review.

PMID:
25388226
20.

A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.

Stanfield BA, Stahl J, Chouljenko VN, Subramanian R, Charles AS, Saied AA, Walker JD, Kousoulas KG.

PLoS One. 2014 Oct 28;9(10):e109890. doi: 10.1371/journal.pone.0109890. eCollection 2014.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk